Session date: 
06/15/2017 - 8:00am to 9:00am

2017 ASCO REVIEW

A Phase Ib Study of Isatuximab plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma (RRMM)

Learning Objectives:

  • Review the options for treatment of relapsed myeloma.
  • Discuss the importance of immunotherapy in myeloma.
  • Outline the potential role of the novel agent Isatuximab in myeloma. 
Joseph Mikhael MD, MEd, FRCPC, FACP  
Professor of Medicine, Mayo College of Medicine
Associate Dean, Mayo School of Graduate Medical Education
Deputy Director - Education, Mayo Clinic Cancer Center
Associate Medical Director, Department of Development
Mayo Clinic
Phoenix, Arizona
________________________________________________________________________
 
Clinical Pharmacology and Experimental Therapeutics Session

Learning Objectives:

  • Review high impact  phase I studies presented at the ASCO 2017 meeting
  • Discuss mechanism of action of novel agents
  • Discuss toxicities and efficacy in different tumor types.

Ramesh Ramanathan, M.D.
Professor of Medicine, Mayo College of Medicine
Senior Associate Consultant, Hematology Medical Oncology
Mayo Clinic
Phoenix, Arizona

________________________________________________________________________

Results of the SIMPLIFY 1 Trial: Momelotinib vs Ruxolitinib in Myelofibrosis

Learning Objectives:

  • Identify the burden of anemia in myelofibrosis
  • Review the outcome of the SIMPLIFY1 trial, and role of momelotinib in MF

Ruben Mesa, M.D.
Professor of Medicine, Mayo College of Medicine
Chair, Division of Hematology Medical Oncology
Deputy Director, Mayo Clinic Cancer Center
Chair, Arizona Cancer Coalition
Consultant, Hematology Medical Oncology
Mayo Clinic
Phoenix, Arizona

LOCATION  Phoenix campus:  WAUGH AUDITORIUM-Side A / Scottsdale campus:  CRB 3-011 and MCS 3-358E

 
A unique presentation code must be sent via text to 507-200-3010 
to record attendance and to ensure you receive CME credit for your attendance.  
NOTE:  Attendees must be present to receive code.
 
ABOUT Cancer Center Grand Rounds are held weekly on Thursdays for faculty and junior faculty, investigators and junior investigators, scholars, graduate students, medical students, research fellows, administration and allied health staff.
 
FACULTY DISCLOSURE  As a provider accredited by Accreditation Council on Continuing Medical Education (ACCME), Mayo Clinic College of Medicine, must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships is included course materials so participants may formulate their own judgments regarding the presentation.
 

ADDITIONAL INFORMATION Light refreshments will be served on the Phoenix campus only.

ARCHIVED PRESENTATIONS Located in Arizona Cancer Center Grand Rounds video library at http://videoexchange.mayo.edu.

Support location: 
Arizona

Please login or register to take this course.
Support location: 
Arizona